Deepverge PLC
LSE:DVRG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.1), the stock would be worth GBX0.15 (0% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.1 | GBX0.15 |
0%
|
| 3-Year Average | 0.1 | GBX0.15 |
0%
|
| 5-Year Average | 0.1 | GBX0.15 |
0%
|
| Industry Average | 1.5 | GBX4.44 |
+2 859%
|
| Country Average | 1.5 | GBX4.44 |
+2 859%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| IE |
|
Deepverge PLC
LSE:DVRG
|
1.1m GBP | 0.1 | -0.5 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
958.5B USD | 132.2 | 3 973.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
173.9B USD | 3.3 | 25.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
127.8B USD | 2.4 | 34.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 6.8 | 46.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
299.9B CNY | 3.8 | 15.7 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.5B CHF | 3.8 | -120.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.7B USD | 4.7 | 25.3 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.4B USD | 11.5 | 45.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.8B USD | 4.3 | 20.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26B USD | -1 098 | 29.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.8 |
| Median | 1.5 |
| 70th Percentile | 2.6 |
| Max | 22.9 |
Other Multiples
Deepverge PLC
Glance View
DeepVerge Plc is a personal health company, which engages in the development and commercialization of technology and products for the human integumentary system. The company is headquartered in Malahide, Dublin. The company went IPO on 2017-04-05. The firm provides core skin and human testing technology. Its is engaged in collaborating technology platforms with partners in artificial intelligence, clinical research, water technologies, medical device and life science. Its collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple partner technologies.
